AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27482888 — intervention group
Group type: EXPERIMENTAL
Intervention: CD19-specific CAR T cells generated using the Sleeping Beauty transposon system and AaPCs
Number of subjects: 26
Study 27482964 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic symptomatic norovirus infection with diarrhea (noro group)
Number of subjects: 15
Study 27482964 — intervention group
Group type: COMPARATOR
Intervention: Chronic diarrhea in the absence of norovirus (control group)
Number of subjects: 15
Study 27482964 — intervention group
Group type: COMPARATOR
Intervention: Comparison of noro group to control group
Number of subjects: 15
Study 27483008 — intervention group
Group type: EXPERIMENTAL
Intervention: BD FACSPresto™ Near-Patient CD4 Counter
Number of subjects: 351
Study 27483391 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimasertib (60 mg oral dose)
Number of subjects: 6
Study 27484458 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention (suggestions before anesthesia)
Number of subjects: 270
Study 27484458 — intervention group
Group type: COMPARATOR
Intervention: Control group (no suggestions before anesthesia)
Number of subjects: 270
Study 27484756 — intervention group
Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 2258
Study 27484756 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2258
Study 27485208 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous TRH administration
Number of subjects: 73
Study 27485822 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray Matters mobile phone app
Number of subjects: 144
Study 27485934 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook-based peer group intervention for mothers with weekly video-based curriculum and optional face-to-face event.
Number of subjects: 8
Study 27485934 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook-based peer group intervention for mothers.
Number of subjects: 8
Study 27486034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir-velpatasvir (400 mg/100 mg) plus GS-9857 (100 mg) once daily for 6-12 weeks
Number of subjects: 197
Study 27486034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir-velpatasvir (400 mg/100 mg) plus GS-9857 (100 mg) once daily for 6-12 weeks plus ribavirin
Number of subjects: 197
Study 27486034 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir-velpatasvir (400 mg/100 mg) plus GS-9857 (100 mg) once daily for 12 weeks
Number of subjects: 197
Study 27486033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir-velpatasvir (400 mg/100 mg fixed-dose combination tablet) and GS-9857 (100 mg) once daily for 6-12 weeks
Number of subjects: 128
Study 27486205 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized prediction model for forced expiratory volume at 1 second (FEV) derived from mixed-effects regression models.
Number of subjects: 5594
Study 27486340 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3350 ASC (17 g once daily for 14 days)
Number of subjects: 65
Study 27486340 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3350 ASC
Number of subjects: 65
Study 27486340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 27486340 — intervention group
Group type: COMPARATOR
Intervention: PEG 3350 ASC and Placebo
Number of subjects: 65
Study 27486524 — intervention group
Group type: EXPERIMENTAL
Intervention: ETN 25 mg + MTX
Number of subjects: 120
Study 27486524 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX
Number of subjects: 120
Study 27486524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 27486524 — intervention group
Group type: EXPERIMENTAL
Intervention: ETN 50 mg + MTX (Phase I)
Number of subjects: 120
Study 27486524 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Phase II)
Number of subjects: 120
Study 27486545 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted collaborative care intervention
Number of subjects: 67
Study 27486629 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab with Perioperative Chemotherapy
Number of subjects: 0
Study 27486629 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab without Pertuzumab
Number of subjects: 0
Study 27486660 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (school-based low-volume high-intensity interval training)
Number of subjects: 101
Study 27486704 — intervention group
Group type: EXPERIMENTAL
Intervention: NL-1000 pedometer
Number of subjects: 60
Study 27486704 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo pedometer
Number of subjects: 60
Study 27486704 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-T2 pedometer
Number of subjects: 60
Study 27486704 — intervention group
Group type: COMPARATOR
Intervention: All pedometers
Number of subjects: 60
Study 27486995 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolite index based on early umbilical cord blood alterations (succinate, glycerol, 3-hydroxybutyrate, O-phosphocholine)
Number of subjects: 31
Study 27486995 — intervention group
Group type: COMPARATOR
Intervention: Standard biochemical markers at birth
Number of subjects: 31
Study 27486995 — intervention group
Group type: COMPARATOR
Intervention: EEG and Sarnat score
Number of subjects: 31
Study 27487311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided ilioinguinal and iliohypogastric nerve block (ILI+IHG)
Number of subjects: 149
Study 27487311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided posterior transversus abdominis plane block (TAP)
Number of subjects: 149
Study 27487311 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nerve block)
Number of subjects: 149
Study 27488238 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet score (self-reported intake of fruit, vegetables, nuts, legumes, whole grains, fish, red meat, monounsaturated fat:saturated fat ratio, and alcohol)
Number of subjects: 4497
Study 27488238 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet score
Number of subjects: 4497
Study 27488509 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 82
Study 27488552 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MCI) including BP screening and home health education by trained community health workers (CHWs); providers trained in hypertension management; compensation of CHWs for additional services.
Number of subjects: 412
Study 27488552 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MCI) for individuals with uncontrolled hypertension at baseline.
Number of subjects: 412
Study 27488552 — intervention group
Group type: EXPERIMENTAL
Intervention: Stakeholder support for MCI strategies.
Number of subjects: 412
Study 27488566 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated electronic Diagnosis Approach (IeDA) - an electronic IMCI protocol provided to nurses
Number of subjects: 0
Study 27488722 — intervention group
Group type: EXPERIMENTAL
Intervention: PECARN clinical decision rule
Number of subjects: 1499
Study 27488898 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological inhibition of BMI1
Number of subjects: 0
Study 27488898 — intervention group
Group type: EXPERIMENTAL
Intervention: Bmi1 haploinsufficiency
Number of subjects: 0
Study 27489076 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 27489204 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconferencing group
Number of subjects: 107
Study 27489204 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face (F2F) group
Number of subjects: 107
Study 27489247 — intervention group
Group type: EXPERIMENTAL
Intervention: My Mobile Advice Program (MyMAP) smoking cessation program
Number of subjects: 66
Study 27489247 — intervention group
Group type: COMPARATOR
Intervention: Standard self-help program
Number of subjects: 66
Study 27490698 — intervention group
Group type: EXPERIMENTAL
Intervention: New Shigella vaccine
Number of subjects: 5
Study 27490698 — intervention group
Group type: EXPERIMENTAL
Intervention: Licensed vaccines
Number of subjects: 5
Study 27490698 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine recipients with neutropenia
Number of subjects: 5
Study 27490698 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects of African descent
Number of subjects: 5
Study 27490698 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings from literature review
Number of subjects: 5
Study 27490919 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-y bypass (RYGB)
Number of subjects: 30
Study 27490919 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 30
Study 27490919 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric band (LAGB)
Number of subjects: 30
Study 27490919 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD)
Number of subjects: 30
Study 27491288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone intervention plus treatment as usual (experimental group)
Number of subjects: 120
Study 27491288 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 120
Study 27491485 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding transcatheter aortic valve replacement (TAVR)
Number of subjects: 3578
Study 27491487 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 27491548 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical impedance vector analysis (BIVA)
Number of subjects: 22
Study 27491548 — intervention group
Group type: COMPARATOR
Intervention: Bioelectrical impedance analysis (BIA)
Number of subjects: 22
Study 27492005 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation (MV)
Number of subjects: 43
Study 27492508 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilator-integrated end-tidal CO2 (ETCO2) monitoring
Number of subjects: 28
Study 27492508 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous CO2 (TcCO2) monitoring
Number of subjects: 28
Study 27492508 — intervention group
Group type: EXPERIMENTAL
Intervention: ETCO2 and TcCO2 monitoring
Number of subjects: 28
Study 27492535 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma control
Number of subjects: 203
Study 27492535 — intervention group
Group type: EXPERIMENTAL
Intervention: Remission
Number of subjects: 203
Study 27492535 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncontrolled asthma predictors
Number of subjects: 203
Study 27492535 — intervention group
Group type: EXPERIMENTAL
Intervention: Protection from uncontrolled asthma
Number of subjects: 203
Study 27492535 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of uncontrolled disease
Number of subjects: 203
Study 27492790 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal decolonization using intranasal mupirocin and chlorhexidine bath (2 cycles, 1 month apart)
Number of subjects: 16773
Study 27492790 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site MRSA surveillance with targeted decolonization
Number of subjects: 16773
Study 27492881 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (brachial plexus block [BPB] with 0.5% L-bupivacaine and 1.5% lidocaine with epinephrine)
Number of subjects: 126
Study 27492881 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthesia (0.5% L-bupivacaine and 1% lidocaine injected subcutaneously)
Number of subjects: 126
Study 27492881 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (BPB)
Number of subjects: 126
Study 27492881 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthesia
Number of subjects: 126
Study 27493133 — intervention group
Group type: EXPERIMENTAL
Intervention: Gather mHealth System
Number of subjects: 0
Study 27493133 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27493790 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg two times a day
Number of subjects: 956
Study 27493790 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg two times a day
Number of subjects: 956
Study 27493790 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 956
Study 27493796 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid-associated ophthalmopathy (TAO) group
Number of subjects: 66
Study 27494163 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine (2 doses, liquid formulation, separated by ≥4 weeks)
Number of subjects: 3040
Study 27494911 — intervention group
Group type: EXPERIMENTAL
Intervention: Decolonization therapy with oral aminoglycosides (gentamicin and neomycin/streptomycin)
Number of subjects: 77
Study 27494911 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin oral therapy
Number of subjects: 77
Study 27494911 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin/streptomycin therapy
Number of subjects: 77
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in the harm of high salt intake
Number of subjects: 4693
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy salt intake behavior
Number of subjects: 4693
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 4693
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 4693
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Health status
Number of subjects: 4693
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Years in school
Number of subjects: 4693
Study 27495056 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of salt intake
Number of subjects: 4693
Study 27495287 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate (0.3, 0.6 and 1.0 mEq/kg/day) for 6 weeks
Number of subjects: 20
Study 27495287 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 20
Study 27495290 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate frequency of coffee intake
Number of subjects: 992
Study 27495743 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (10 °C, left hand) as conditioning stimulus (CS)
Number of subjects: 25
Study 27495743 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat pain (43-49 °C, pain intensity 60 ± 5 on the 101-point numeric rating scale, right forearm) as test stimulus (TS)
Number of subjects: 25
Study 27495752 — intervention group
Group type: EXPERIMENTAL
Intervention: Extravascular lung water (EVLWi)
Number of subjects: 47
Study 27495752 — intervention group
Group type: EXPERIMENTAL
Intervention: PaO2/FiO2 ratio
Number of subjects: 47
Study 27495752 — intervention group
Group type: EXPERIMENTAL
Intervention: sRAGE
Number of subjects: 47
Study 27495955 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented red ginseng
Number of subjects: 15
Study 27495959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound visualization of the axillary vein
Number of subjects: 50
Study 27495959 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound visualization of the subclavian vein
Number of subjects: 50
Study 27496260 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PPV)
Number of subjects: 110
Study 27496264 — intervention group
Group type: EXPERIMENTAL
Intervention: Cushing syndrome patients before surgery
Number of subjects: 54
Study 27496264 — intervention group
Group type: EXPERIMENTAL
Intervention: Cushing syndrome patients after surgery
Number of subjects: 54
Study 27496264 — intervention group
Group type: EXPERIMENTAL
Intervention: Cushing syndrome patients
Number of subjects: 54
Study 27496270 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI categorization for identifying excess adiposity
Number of subjects: 10465
Study 27496270 — intervention group
Group type: EXPERIMENTAL
Intervention: Excess adiposity cutpoints (75th, 85th, 90th percentiles of DXA body fat)
Number of subjects: 10465
Study 27496270 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of excess adiposity
Number of subjects: 10465
Study 27496270 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI categorization
Number of subjects: 10465
Study 27496276 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency ultrasound measurement of skin thickness
Number of subjects: 0
Study 27496798 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoantibody positive subjects (auto-AB+)
Number of subjects: 986
Study 27496798 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 986
Study 27496798 — intervention group
Group type: EXPERIMENTAL
Intervention: Wilson disease
Number of subjects: 986
Study 27496798 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment
Number of subjects: 986
Study 27496798 — intervention group
Group type: EXPERIMENTAL
Intervention: Known diagnoses other than AIH
Number of subjects: 986
Study 27496946 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (25-OHD <25 nmol/l)
Number of subjects: 1248
Study 27496946 — intervention group
Group type: COMPARATOR
Intervention: Normal vitamin D levels (25-OHD >75 nmol/l)
Number of subjects: 1248
Study 27496946 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ionized calcium (Ca(2+))
Number of subjects: 1248
Study 27497181 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) fluorescence imaging method
Number of subjects: 99
Study 27497181 — intervention group
Group type: COMPARATOR
Intervention: Blue dye method
Number of subjects: 99
Study 27497862 — intervention group
Group type: EXPERIMENTAL
Intervention: CTX-DP (2 million, 5 million, 10 million, or 20 million cells by stereotactic ipsilateral putamen injection)
Number of subjects: 11
Study 27498122 — intervention group
Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiography (TTE) for assessing right ventricular (RV) dysfunction
Number of subjects: 400
Study 27498122 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of ≥1 echocardiographic signs of RV dysfunction
Number of subjects: 400
Study 27498122 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of ≥2 echocardiographic signs of RV dysfunction
Number of subjects: 400
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF)
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean body mass (LBM)
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat mass (FM)
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Early transmitral flow velocity to early mitral annular velocity
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial internal diameter
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPSE
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: LBM
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: CRF
Number of subjects: 233
Study 27499218 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin A1c
Number of subjects: 233
Study 27499222 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-procedural unfractioned heparin
Number of subjects: 5997
Study 27499222 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-procedural 600mg clopidogrel loading dose
Number of subjects: 5997
Study 27499222 — intervention group
Group type: COMPARATOR
Intervention: No-reflow
Number of subjects: 5997
Study 27499309 — intervention group
Group type: EXPERIMENTAL
Intervention: Most active accelerometry quartile (25 minutes/week of moderate to vigorous physical activity, 2,150 steps/day)
Number of subjects: 65
Study 27499309 — intervention group
Group type: COMPARATOR
Intervention: Lowest activity quartile (less than 5 min/week of MVPA, fewer than 460 steps/day)
Number of subjects: 65
Study 27499694 — intervention group
Group type: EXPERIMENTAL
Intervention: E/E' ratio goal-directed therapy in kidney recipients with baseline diastolic dysfunction
Number of subjects: 242
Study 27499694 — intervention group
Group type: EXPERIMENTAL
Intervention: E/E' ratio
Number of subjects: 242
Study 27499948 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation cobalt-chromium sirolimus-eluting stent (CoCr-SES)
Number of subjects: 0
Study 27499948 — intervention group
Group type: COMPARATOR
Intervention: Extended-use group
Number of subjects: 0
Study 27499948 — intervention group
Group type: COMPARATOR
Intervention: Standard-use group
Number of subjects: 0
Study 27499979 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR thoracoscope with indocyanine green (ICG) at a dosage of 0.2 mg/kg
Number of subjects: 2
Study 27499979 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR thoracoscope with indocyanine green (ICG) at a dosage of 0.6 mg/kg
Number of subjects: 2
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: African American women
Number of subjects: 285
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial hCG values < 1,500
Number of subjects: 285
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial hCG values 1,500-3,000
Number of subjects: 285
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial hCG values > 3,000
Number of subjects: 285
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior miscarriage
Number of subjects: 285
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of bleeding
Number of subjects: 285
Study 27500326 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of pain
Number of subjects: 285
Study 27500329 — intervention group
Group type: EXPERIMENTAL
Intervention: Second uterine curettage
Number of subjects: 60
Study 27501514 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial form of periodontal care
Number of subjects: 27
Study 27501514 — intervention group
Group type: COMPARATOR
Intervention: Control group (periodontally healthy)
Number of subjects: 27
Study 27501608 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative Epidural Analgesia
Number of subjects: 364
Study 27501618 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (SA)
Number of subjects: 152
Study 27501618 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 152
Study 27501792 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortical blood flow estimation method
Number of subjects: 0
Study 27501792 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortex-based estimation of elevated mPAP
Number of subjects: 0